My Quote Request
No products added yet
6505-01-285-7473
20 Products
TAZIDIME
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012857473
NSN
6505-01-285-7473
TAZIDIME
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012857473
NSN
6505-01-285-7473
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 1GM VIAL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 18 ML CAPACITY GLASS VIAL WITH DOUBLE LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715; EACH VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD; 118 MG SODIUM CARBONATE
Related Searches:
NDC00264-1216-10
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012857474
NSN
6505-01-285-7474
NDC00264-1216-10
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012857474
NSN
6505-01-285-7474
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/W DEXTROSE ACTIVE INGREDIENT AND 0.200 PERCENTAGE, W/W SODIUM CHLORIDE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
Related Searches:
S6161
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012857474
NSN
6505-01-285-7474
S6161
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012857474
NSN
6505-01-285-7474
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/W DEXTROSE ACTIVE INGREDIENT AND 0.200 PERCENTAGE, W/W SODIUM CHLORIDE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
Related Searches:
NDC00264-1800-10
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012857475
NSN
6505-01-285-7475
NDC00264-1800-10
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012857475
NSN
6505-01-285-7475
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
S8001
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012857475
NSN
6505-01-285-7475
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC11701-0005-16
METHYLBENZETHONIUM CHLORIDE DUSTING POWDER
NSN, MFG P/N
6505012857867
NSN
6505-01-285-7867
NDC11701-0005-16
METHYLBENZETHONIUM CHLORIDE DUSTING POWDER
NSN, MFG P/N
6505012857867
NSN
6505-01-285-7867
MFG
SWEEN CORP
Description
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 OUNCES
PRIMARY CONTAINER TYPE: CAN, SHAKER-SIFTER
SPECIAL FEATURES: CONTAINS METHYBENZETHONIUM CHLORIDE,SODIUM BICARBONATE,AND SILICA IN A CORNSTARCH BASE
Related Searches:
NDC00173-0363-00
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505012859011
NSN
6505-01-285-9011
NDC00173-0363-00
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505012859011
NSN
6505-01-285-9011
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS RANITIDINE PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE INJECTION USP 25MG/ML 40ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
Related Searches:
ZANTAC
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505012859011
NSN
6505-01-285-9011
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS RANITIDINE PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE INJECTION USP 25MG/ML 40ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
Related Searches:
ZANTAC INJECTION
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505012859011
NSN
6505-01-285-9011
ZANTAC INJECTION
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505012859011
NSN
6505-01-285-9011
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS RANITIDINE PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE INJECTION USP 25MG/ML 40ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
Related Searches:
6616
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505012859918
NSN
6505-01-285-9918
6616
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505012859918
NSN
6505-01-285-9918
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 95.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 POUNDS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: DUAL FLEX TIP WITH RETENTION CUFF,GLOVE,AND LUBRICANT
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00224-0621-36
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505012859918
NSN
6505-01-285-9918
NDC00224-0621-36
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505012859918
NSN
6505-01-285-9918
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 95.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 POUNDS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: DUAL FLEX TIP WITH RETENTION CUFF,GLOVE,AND LUBRICANT
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
ANASPAZ
HYOSCYAMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012860961
NSN
6505-01-286-0961
ANASPAZ
HYOSCYAMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012860961
NSN
6505-01-286-0961
MFG
B F ASCHER & COMPANY INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.125 MILLIGRAMS HYOSCYAMINE SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYOSCYAMINE SULFATE TABLETS USP 0.125MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ANASPAZ TABLETS
HYOSCYAMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012860961
NSN
6505-01-286-0961
ANASPAZ TABLETS
HYOSCYAMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012860961
NSN
6505-01-286-0961
MFG
B F ASCHER & COMPANY INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.125 MILLIGRAMS HYOSCYAMINE SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYOSCYAMINE SULFATE TABLETS USP 0.125MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00225-0295-20
HYOSCYAMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012860961
NSN
6505-01-286-0961
NDC00225-0295-20
HYOSCYAMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012860961
NSN
6505-01-286-0961
MFG
B F ASCHER & COMPANY INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.125 MILLIGRAMS HYOSCYAMINE SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYOSCYAMINE SULFATE TABLETS USP 0.125MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
F91C315
FRUCTOSE,DEXTROSE,AND ORTHOPHOSPHORIC ACID SOLUTION
NSN, MFG P/N
6505012860962
NSN
6505-01-286-0962
F91C315
FRUCTOSE,DEXTROSE,AND ORTHOPHOSPHORIC ACID SOLUTION
NSN, MFG P/N
6505012860962
NSN
6505-01-286-0962
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.800 GRAMS DEXTROSE PER 5 MILLILITERS AND 21.250 MILLIGRAMS PHOSPHORIC ACID PER 5 MILLILITERS AND 1.870 GRAMS FRUCTOSE PER 5 MILLILITERS
FLAVOR: LEMON-MINT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVULOSE DEXTROSE AND ORTHOPHOSPHORIC ACID SOLUTION 4FL OZ
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ADRIA LABS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00009-7573-01
FRUCTOSE,DEXTROSE,AND ORTHOPHOSPHORIC ACID SOLUTION
NSN, MFG P/N
6505012860962
NSN
6505-01-286-0962
NDC00009-7573-01
FRUCTOSE,DEXTROSE,AND ORTHOPHOSPHORIC ACID SOLUTION
NSN, MFG P/N
6505012860962
NSN
6505-01-286-0962
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.800 GRAMS DEXTROSE PER 5 MILLILITERS AND 21.250 MILLIGRAMS PHOSPHORIC ACID PER 5 MILLILITERS AND 1.870 GRAMS FRUCTOSE PER 5 MILLILITERS
FLAVOR: LEMON-MINT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVULOSE DEXTROSE AND ORTHOPHOSPHORIC ACID SOLUTION 4FL OZ
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ADRIA LABS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00013-2113-45
FRUCTOSE,DEXTROSE,AND ORTHOPHOSPHORIC ACID SOLUTION
NSN, MFG P/N
6505012860962
NSN
6505-01-286-0962
NDC00013-2113-45
FRUCTOSE,DEXTROSE,AND ORTHOPHOSPHORIC ACID SOLUTION
NSN, MFG P/N
6505012860962
NSN
6505-01-286-0962
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.800 GRAMS DEXTROSE PER 5 MILLILITERS AND 21.250 MILLIGRAMS PHOSPHORIC ACID PER 5 MILLILITERS AND 1.870 GRAMS FRUCTOSE PER 5 MILLILITERS
FLAVOR: LEMON-MINT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVULOSE DEXTROSE AND ORTHOPHOSPHORIC ACID SOLUTION 4FL OZ
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ADRIA LABS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00067-0240-60
FRUCTOSE,DEXTROSE,AND ORTHOPHOSPHORIC ACID SOLUTION
NSN, MFG P/N
6505012860962
NSN
6505-01-286-0962
NDC00067-0240-60
FRUCTOSE,DEXTROSE,AND ORTHOPHOSPHORIC ACID SOLUTION
NSN, MFG P/N
6505012860962
NSN
6505-01-286-0962
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.800 GRAMS DEXTROSE PER 5 MILLILITERS AND 21.250 MILLIGRAMS PHOSPHORIC ACID PER 5 MILLILITERS AND 1.870 GRAMS FRUCTOSE PER 5 MILLILITERS
FLAVOR: LEMON-MINT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVULOSE DEXTROSE AND ORTHOPHOSPHORIC ACID SOLUTION 4FL OZ
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ADRIA LABS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CLAFORAN
CEFOTAXIME INJECTION,USP
NSN, MFG P/N
6505012861004
NSN
6505-01-286-1004
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFOTAXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOTAXIME INJECTION USP 2GM EQIV 50ML BAG 24S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: SINGLE DOSE IN 5 PERCENT DEXTROSE; BAG SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE FOLLOWING STOCK LISTED IV ADMINISTRATION SETS: 6515-00-115-0032,6515-00-140-0888,6515-01-105-0614,6515-01-153-4703,6515-00-185-51
TOTAL PRIMARY CONTAINER QUANTITY: 24
~1: 58,6515-00-484-0484,6515-01-082-1021,6515-01-153-5669
Related Searches:
CLAFORAN INJECTION
CEFOTAXIME INJECTION,USP
NSN, MFG P/N
6505012861004
NSN
6505-01-286-1004
CLAFORAN INJECTION
CEFOTAXIME INJECTION,USP
NSN, MFG P/N
6505012861004
NSN
6505-01-286-1004
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFOTAXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOTAXIME INJECTION USP 2GM EQIV 50ML BAG 24S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: SINGLE DOSE IN 5 PERCENT DEXTROSE; BAG SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE FOLLOWING STOCK LISTED IV ADMINISTRATION SETS: 6515-00-115-0032,6515-00-140-0888,6515-01-105-0614,6515-01-153-4703,6515-00-185-51
TOTAL PRIMARY CONTAINER QUANTITY: 24
~1: 58,6515-00-484-0484,6515-01-082-1021,6515-01-153-5669
